Effects of Sacubitril/Valsartan on biomarkers of fibrosis and inflammation in patients with heart failure with reduced ejection fraction

被引：0
|
作者：
Giovanni Battista Bolla
Antonella Fedele
Andrea Faggiano
Carla Sala
Gloria Santangelo
Stefano Carugo
机构：
[1] University of Milan and Fondazione IRCCS Ca’ GrandaOspedale Maggiore Policlinico,Department of Clinical Sciences and Community Health
[2] Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico,Cardiology Unit, Internal Medicine Department
[3] University of Milan,Division of Cardiology, Department of Health Sciences, San Paolo Hospital
来源：
BMC Cardiovascular Disorders | / 22卷
关键词：
Heart failure; Sacubitril/Valsartan; Biomarkers; Fibrosis; Left ventricular ejection fraction;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Effects of Sacubitril-Valsartan in Heart Failure With Preserved Ejection Fraction in Patients Undergoing Peritoneal Dialysis
    Fu, Sha
    Xu, Zhenjian
    Lin, Baojuan
    Chen, Junzhe
    Huang, Qiuyan
    Xu, Yanchun
    Xu, Anping
    Chen, Yangxin
    Tang, Ying
    FRONTIERS IN MEDICINE, 2021, 8
  • [42] Cardiometabolic effects of sacubitril/valsartan in a rat model of heart failure with preserved ejection fraction
    Morana-Fernandez, Sandra
    Vazquez-Abuin, Xocas
    Aragon-Herrera, Alana
    Anido-Varela, Laura
    Garcia-Seara, Javier
    Otero-Garcia, Oscar
    Rodriguez-Penas, Diego
    Campos-Toimil, Manuel
    Otero-Santiago, Manuel
    Rodrigues, Alexandre
    Goncalves, Alexandre
    Morais, Juliana Pereira
    Alves, Ines N.
    Sousa-Mendes, Claudia
    Falcao-Pires, Ines
    Gonzalez-Juanatey, Jose Ramon
    Feijoo-Bandin, Sandra
    Lago, Francisca
    BIOCHEMICAL PHARMACOLOGY, 2024, 230
  • [43] Reverse remodelling by sacubitril/valsartan predicts the prognosis in heart failure with reduced ejection fraction
    Moon, Mi-Gil
    Hwang, In-Chang
    Choi, Wonsuk
    Cho, Goo-Yeong
    Yoon, Yeonyee E.
    Park, Jun-Bean
    Lee, Seung-Pyo
    Kim, Hyung-Kwan
    Kim, Yong-Jin
    ESC HEART FAILURE, 2021, 8 (03): : 2058 - 2069
  • [44] Electrocardiographic predictors of response to sacubitril/valsartan therapy in heart failure with reduced ejection fraction
    Shpigelman, Jonathan
    Blaine, Ciara
    Nugent, Carol-Ann
    Kiernan, Louise
    Cahir, Caitriona
    Mac Curtain, Benjamin
    Bachari, Amir
    Irfan, Wadeed
    O'Boyle, Patrick
    O'Neill, James
    Daly, Michael
    JOURNAL OF ELECTROCARDIOLOGY, 2024, 84 : 104 - 108
  • [45] Association of Sacubitril/Valsartan with Metabolic Parameters in Patients with Reduced Ejection Fraction Heart Failure at a Multidisciplinary Clinic
    Ryu, Rachel
    Tran, Huyentran
    Bahjri, Khaled
    METABOLIC SYNDROME AND RELATED DISORDERS, 2021, 19 (02) : 115 - 118
  • [46] Sacubitril/Valsartan Improves Autonomic Function and Cardiopulmonary Parameters in Patients with Heart Failure with Reduced Ejection Fraction
    Giallauria, Francesco
    Vitale, Giuseppe
    Pacileo, Mario
    Di Lorenzo, Anna
    Oliviero, Alessandro
    Passaro, Francesco
    Calce, Roberta
    Parlato, Alessandro
    Testa, Crescenzo
    D'Ambrosio, Giuseppe
    Romano, Giuseppe
    Clemenza, Francesco
    Sarullo, Silvia
    Venturini, Elio
    Gentile, Marco
    Nugara, Cinzia
    Iannuzzo, Gabriella
    DAndrea, Antonello
    Vigorito, Carlo
    Sarullo, Filippo M.
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (06) : 1 - 15
  • [47] The effect of Sacubitril/Valsartan on cardiac function and cardiac remodeling in patients with heart failure with reduced ejection fraction
    Chen, Fangyuan
    Tian, Gang
    Bai, Xiaojun
    Li, Juanli
    Yuan, Zuyi
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (08) : 8684 - 8691
  • [48] Impact of Sacubitril-Valsartan Treatment on Diastolic Function in Patients with Heart Failure and Reduced Ejection Fraction
    Pericas, Pere
    Mas-Llado, Caterina
    Ramis-Barcelo, Maria Francisca
    Valadron, Isabel
    Noris Mora, Marta
    Pasamar Marquez, Lucia
    Gonzalez Colino, Rosa
    Forteza Alberti, Jose Francisco
    Peral Disdier, Vicente
    Rossello, Xavier
    HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION, 2021, 28 (02) : 167 - 175
  • [49] Combined treatment with sacubitril/valsartan plus dapagliflozin in patients affected by heart failure with reduced ejection fraction
    Jiang, Juan
    Gao, Jie
    Zhang, Xiuzhen
    Li, Yuanmin
    Dang, Heqin
    Liu, Yanlin
    Chen, Wenwen
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [50] The Effect of Sacubitril-Valsartan on Ventricular Arrhythmia Burden in Patients With Heart Failure With Reduced Ejection Fraction
    Medeiros, Paulo
    Coelho, Claudia
    Costa-Oliveira, Catia
    Rocha, Sergia
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (02)
12345